U.S. Pharma Stock News

NWPX Infrastructure, Inc. recently completed the first real‑world installation of its patent‑pending Permalok Radial Bending Joint technology during an emergency wastewater microtunneling project beneath New Jersey’s Pleasure Bay, enabling steel casing pipe to follow intentionally curved underground routes. This field proof-of-concept created what the company describes as the world’s first intentionally curved steel microtunnel, opening up new options for trenchless water and wastewater...

Recently, CVS Health expanded access to GLP-1 weight management drugs by reintroducing Zepbound and easing access to Foundayo, while also ramping up AI use across pharmacy operations and mental health services. These moves highlight CVS Health's push to use advanced technology and broader drug coverage to make care more accessible and cost-effective across its integrated platform. Next, we’ll examine how the expanded GLP-1 coverage could influence CVS Health’s investment narrative and...

In recent days, First Solar updated guidance to include an estimated US$2.10–US$2.19 billion in Section 45X manufacturing tax credits while facing policy and trade uncertainties, including a U.S. International Trade Commission investigation into certain solar products. At the same time, significant insider stock sales and wider geopolitical jitters have heightened investor focus on the company’s risk profile despite supportive U.S. incentives. We’ll now examine how heightened policy and...

Arm Holdings (NasdaqGS:ARM) has been swinging sharply as semiconductor stocks react to cautious commentary from peers, profit taking, and wider risk off sentiment. Sector mood rather than company headlines is in the driver’s seat. See our latest analysis for Arm Holdings. The stock’s recent 11.32% 1 day share price return follows a period of profit taking and sector wide volatility, but its 64.60% 30 day and 198.29% year to date share price returns point to strong, albeit choppy, momentum,...

Prudential Financial (NYSE:PRU) has extended its suspension of new sales in Japan, affecting one of its key international markets. Following the extended suspension, Argus downgraded its rating on Prudential Financial, citing the Japan business challenges. Insider selling activity at Prudential Financial has increased around the time of these developments. For investors tracking NYSE:PRU, these company specific events come as the stock trades at $106.51, with the share price up 3.1% over...

Teva Pharmaceutical Industries (NYSE:TEVA) has completed its acquisition of Emalex Biosciences. The deal adds ecopipam, an FDA-designated orphan drug candidate for pediatric Tourette syndrome, to Teva's late-stage neuroscience pipeline. This move aligns with Teva's Pivot to Growth strategy by increasing its focus on specialty neuroscience assets. For investors tracking NYSE:TEVA, the Emalex deal follows a period of strong stock performance, with the share price at $34.56 and the 1-year...

Waters Corporation (NYSE:WAT) has launched new BioResolve and GTxResolve Columns aimed at speeding impurity analysis in biopharmaceutical workflows. The company introduced two mass spectrometry platforms, the Cyclic IMS P20 and Xevo MRT P10, designed to increase speed, sensitivity, and multiomics capabilities. Waters also released a new Coin Cell DSC instrument focused on safer battery development and testing. Waters, known for its analytical instruments and consumables, is leaning into...

In early June 2026, Cadence Design Systems announced an expanded multi‑year collaboration with Intel Foundry on Design Technology Co‑Optimization for Intel’s 14A process, while Hitachi and Phison separately unveiled new partnerships with Intel spanning foundry tools, quantum computing, physical AI, and enabling larger AI models on Intel-powered PCs. Taken together with a large 2028 Google TPU manufacturing order and new rackscale AI and Xeon 6+ launches, these alliances strengthen Intel’s...

KKR, Kuwait Investment Authority, Nvidia, and Vistra recently launched Helix Digital Infrastructure, a more than US$10.00 billion AI data center venture that designates Vistra as its preferred power provider for hyperscale facilities. This role anchors Vistra at the center of coordinating large-scale, long-duration power supply for AI infrastructure, tying its generation fleet directly to the energy-hungry buildout of next-generation data centers. We’ll now examine how Vistra’s role as...

If you are wondering whether ResMed at around US$192 per share offers value or just more volatility, the starting point is understanding what the current price actually reflects. The stock is down 1.0% over the past week, 5.6% over the past month, and 21.4% year to date, with a 23.0% decline over the last year and 16.4% over five years, which may change how investors are thinking about both risk and opportunity. Much of the recent conversation around ResMed has focused on how the company is...

Whirlpool (WHR) has drawn fresh attention after recent share performance data showed mixed returns, including gains over the past week and month alongside declines over the past 3 months and year to date. See our latest analysis for Whirlpool. At a share price of US$42.41, Whirlpool’s recent performance has been mixed, with short term momentum improving, such as a 7 day share price return of 6.02%, against a much weaker multi year total shareholder return, including a 5 year total shareholder...

In recent days, commentary around H.B. Fuller has highlighted its 57-year dividend growth record and reputation as a leading global adhesives manufacturer, with some analysts arguing that the shares appear materially undervalued relative to the company’s long-term fundamentals. This focus on dividend durability and perceived undervaluation has reinforced the view that H.B. Fuller’s capital return discipline is a core pillar of its investment appeal. Against that backdrop, we’ll explore how...

Parsons (PSN) stock is drawing fresh attention after a series of U.S. Air Force Research Laboratory contracts tied to the GARDEM 2 program and a successful AI-enabled counter drone systems demonstration in operational conditions. See our latest analysis for Parsons. Those contract wins and AI-enabled defense milestones come as Parsons’ 1 month share price return of 8.69% contrasts with a year to date share price decline of 7.92%. Over the same period, the 1 year total shareholder return has...

Worthington Steel, Inc. was recently named a GM Supplier of the Year winner in General Motors' 34th annual Supplier of the Year awards, marking its fifth recognition since 2020 and third consecutive win. This continued acknowledgement from a major global automaker underscores Worthington Steel’s ongoing role in supporting critical automotive supply chains and innovation initiatives. We’ll now examine how Worthington Steel’s repeated GM Supplier of the Year recognition might influence its...

Opendoor Technologies is closing its India operations to centralize work in the U.S. The company plans to build AI native teams in the U.S., reshaping how it allocates global resources. This shift reflects how AI is influencing both product workflows and traditional outsourcing models. For investors tracking NasdaqGS:OPEN, this move comes as the stock trades around $4.47 and has had a very large 1 year return, while still being down 73.4% over 5 years and 26.4% year to date. The decision to...

Recent performance snapshot Abbott Laboratories (ABT) has seen mixed share performance recently, with the stock edging up about 0.5% in the latest session and showing a gain over the past month but declines over the past 3 months and year to date. See our latest analysis for Abbott Laboratories. The latest moves come against a weak backdrop, with the share price down about 17% over the past 90 days and the 1 year total shareholder return declining roughly 33%. As a result, recent momentum...

Clover Health Investments (NasdaqGS:CLOV) secured a court ruling requiring the Centers for Medicare & Medicaid Services to recalculate its 2026 Medicare Star Rating. The US District Court decision results in an upgrade for Clover Health's main PPO plan from 3.5 to 4.5 stars. The higher rating is expected to increase future CMS bonus payments tied to that plan's performance. The ruling reverses a prior downgrade and strengthens Clover Health's position within the Medicare Advantage...

Seagate Technology Holdings (NasdaqGS:STX) has secured near-full allocation of its nearline hard drive capacity through calendar 2027. The long term commitments are backed by multi year purchase agreements with key customers. Management has raised its annual revenue growth target to at least 20% based on this contracted demand. For investors watching Seagate at a share price of $868.09, this capacity lock in comes after a period of very strong stock performance, including a return of 201.9%...

The Morning Bull - US Market Morning Update Friday, Jun, 12 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up around 0.8%, as investors weigh stubborn energy driven inflation against hopes the Federal Reserve can stay patient on interest rates. May consumer prices in the US rose 0.5% in a single month, with gasoline up 7%, which keeps the pressure on household budgets and mortgage rates, now at 6.6%. At the same time, producer prices for May are expected...

Lumentum Holdings (NasdaqGS:LITE) CEO highlighted near-packaged optics, or NPO, as a major new growth driver for the company. Management indicated that NPO could become a larger opportunity than the current focus on co-packaged optics, or CPO. The CEO pointed to a potentially meaningful impact from NPO beginning in fiscal 2027 to 2028. Lumentum operates in optical and photonics technologies that sit inside the broader semiconductor and AI infrastructure supply chain. As data centers scale...

Axsome Therapeutics (AXSM) has drawn attention after recent trading, with the stock closing at US$253.77. Investors are weighing this move against the company’s central nervous system focused drug portfolio and ongoing clinical programs. See our latest analysis for Axsome Therapeutics. The recent 3.02% 1 day share price return, along with a 62.59% 90 day share price return and 138.84% 1 year total shareholder return, points to strong momentum as investors reassess Axsome Therapeutics’ CNS...

If you are wondering whether Hecla Mining's current share price offers value or is running ahead of itself, the next sections break down what the numbers actually say about the stock. The share price closed at US$14.99, with the stock down 10.9% over the past week and 27.1% over the past month, although the 1-year return of 150.5% and 3-year return of 190.3% still stand out. These swings in performance have kept Hecla Mining on many investors' watchlists, as the stock has moved sharply both...

Metropolitan Bank Holding (MCB) has recently drawn investor attention after its stock closed at $96.18, with performance over the past month and past 3 months prompting closer scrutiny of this regional bank. See our latest analysis for Metropolitan Bank Holding. The recent 2.44% 1 day share price return, alongside a 24.96% year to date share price return and a 47.12% 1 year total shareholder return, points to momentum that investors are weighing against the current valuation and risk...

In recent days, GPGI completed its conversion to a Nevada corporation, saw all 2026 annual meeting proposals approved, and CompoSecure appointed Ian Snadden as Chief Commercial Officer, International to lead global sales efforts. Taken together, the governance shift, auditor appointment and new international commercial leadership highlight a corporate focus on legal flexibility and overseas expansion at a time of operational and market challenges. Next, we’ll examine how GPGI’s move to...